Morgan Stanley
FLACU

Morgan Stanley’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Morgan Stanley’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100
Closed -$1K – 8291
2021
Q4 		$1K Hold
100
– – ﹤0.01% 7931
2021
Q3 		$1K Sell
100
-370
-79% -$3.71K ﹤0.01% 7879
2021
Q2 		$5K Hold
470
– – ﹤0.01% 7413
2021
Q1 		$5K Buy
470
+370
+370% +$3.94K ﹤0.01% 7133
2020
Q4 		$1K Buy
+100
New +$1.04K ﹤0.01% 6994

Other funds holding FLACU

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Morgan Stanley's FLACU Position: Q1 2022 in Review

Morgan Stanley sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q1 2022, closing a stake of 100 shares — an estimated $1K sold.

Morgan Stanley first reported a position in FLACU in Q4 2020 and held it in 5 quarters. The position peaked at $5K in Q2 2021. 21 funds tracked by Wall St. Rank hold FLACU as of Q1 2022.

  • Morgan Stanley reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
  • Morgan Stanley sold 100 Frazier Lifesciences Acquisition Corporation Unit shares in Q1 2022, an estimated $1K.
  • Morgan Stanley first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 5 quarters.
  • Morgan Stanley's Frazier Lifesciences Acquisition Corporation Unit position peaked at $5K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q1 2022.

Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.